VYGR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.00%

Insider Buying (Last 12 Months): $2,663,552.00

Insider Selling (Last 12 Months): $4,060,791.92

Voyager Therapeutics Insider Trading History Chart

Voyager Therapeutics Share Price & Price History

^$6.22

▼ -0.23 (-3.57%)

As of 12/5/2022 04:32 PM ET

Days: 30 | 90 | 365

Top Innovation Stock

From PressReach | Ad

Today's stock market report features an AI Robotics tech stock with a $4 million order backlog.

Click here for the name and ticker

Voyager Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/24/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	149,972	$6.09	$913,329.48	5,628,933
8/15/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	135,808	$6.04	$820,280.32	5,907,361
8/12/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	348,007	$6.12	$2,129,802.84	6,043,169
7/14/2022	Glenn Pierce	Director	Sell	9,512	$6.70	$63,730.40	16,788
6/23/2022	Ecor1 Capital, Llc	Major Shareholder	Buy	376,000	$5.66	$2,128,160.00	4,753,907
6/21/2022	Ecor1 Capital, Llc	Major Shareholder	Buy	101,400	$5.28	$535,392.00	4,377,907
4/4/2022	Robert W Hesslein	VP	Sell	2,786	$8.25	$22,984.50	114,963
4/4/2022	Robin Swartz	COO	Sell	1,527	$8.25	$12,597.75	52,060
3/21/2022	Robert W Hesslein	VP	Sell	4,955	$8.29	$41,076.95
3/21/2022	Robin Swartz	COO	Sell	4,413	$8.29	$36,583.77
2/11/2022	Robert W Hesslein	VP	Sell	3,252	$3.36	$10,926.72
1/12/2022	Julie Burek	VP	Sell	265	$3.06	$810.90
1/3/2022	Julie Burek	VP	Sell	3,063	$2.83	$8,668.29
1/12/2021	Allison Dorval	CFO	Sell	2,942	$8.62	$25,360.04	49,080
1/12/2021	Andre Turenne	CEO	Sell	10,443	$8.62	$90,018.66	156,352
5/21/2020	Omar Khwaja	Insider	Sell	3,500	$12.96	$45,360.00	56,500
4/3/2020	Robert W Hesslein	VP	Sell	3,091	$8.51	$26,304.41	52,534
1/21/2020	Allison Dorval	CFO	Sell	3,128	$13.36	$41,790.08
1/21/2020	Andre Turenne	CEO	Sell	10,705	$13.36	$143,018.80	85,545
1/21/2020	Matthew P Ottmer	COO	Sell	3,724	$13.36	$49,752.64	26,276

Are Investors Returning to the Small-Cap Uranium Sector?

From Investing Trends | Ad

Back in the early 2000's, small-cap Paladin Energy was the darling of the last uranium boom when it shot up from ten cents to over nine dollars.

Today's uranium supply/demand imbalance has a lot in common with the last market cycle. Combined with the energy crisis and "green revolution," this could be setting the stage for the next uranium boom.

Get the Full Story on Uranium Opportunities Here

SEC Filings (Institutional Ownership Changes) for Voyager Therapeutics (NASDAQ:VYGR)

59.42% of Voyager Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Voyager Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2022	Vanguard Group Inc.	1,896,814	$11.23M	0.0%	-4.7%	4.913%
11/15/2022	Price T Rowe Associates Inc. MD	843,711	$5M	0.0%	+1.9%	2.185%
11/15/2022	Marshall Wace LLP	189,736	$1.12M	0.0%	N/A	0.491%
11/15/2022	Federated Hermes Inc.	605,795	$3.59M	0.0%	-1.2%	1.569%
11/15/2022	BlackRock Inc.	590,504	$3.50M	0.0%	+4.7%	1.529%
11/14/2022	Armistice Capital LLC	3,396,000	$20.10M	0.3%	+32.4%	8.796%
11/14/2022	Royal Bank of Canada	12,004	$71K	0.0%	+1,746.8%	0.031%
11/14/2022	Point72 Asset Management L.P.	289,420	$1.71M	0.0%	N/A	0.750%
11/14/2022	Cubist Systematic Strategies LLC	35,693	$0.21M	0.0%	-42.9%	0.092%
11/14/2022	Renaissance Technologies LLC	116,800	$0.69M	0.0%	+23.9%	0.303%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	112,155	$0.66M	0.0%	-6.7%	0.290%
11/10/2022	Hillsdale Investment Management Inc.	87,967	$0.52M	0.0%	+347.3%	0.228%
11/10/2022	Dimensional Fund Advisors LP	94,023	$0.56M	0.0%	-14.9%	0.243%
11/7/2022	Jump Financial LLC	26,000	$0.15M	0.0%	-27.3%	0.067%
11/3/2022	TRV GP Iii LLC	5,428,933	$32.14M	14.0%	-15.1%	14.047%
10/27/2022	Assenagon Asset Management S.A.	16,224	$96K	0.0%	-17.8%	0.042%
10/25/2022	Raymond James Financial Services Advisors Inc.	37,788	$0.22M	0.0%	+11.6%	0.098%
10/18/2022	Bailard Inc.	28,900	$0.17M	0.0%	N/A	0.075%
9/16/2022	Federated Hermes Inc.	613,047	$3.62M	0.0%	-1.9%	1.586%
8/22/2022	ExodusPoint Capital Management LP	10,787	$64K	0.0%	-30.8%	0.028%
8/19/2022	Walleye Capital LLC	38,906	$0.23M	0.0%	-74.2%	0.101%
8/18/2022	Goldman Sachs Group Inc.	109,841	$0.65M	0.0%	-3.3%	0.284%
8/16/2022	Price T Rowe Associates Inc. MD	827,950	$4.89M	0.0%	+1,735.8%	2.142%
8/15/2022	Occudo Quantitative Strategies LP	36,152	$0.21M	0.0%	+151.2%	0.094%
8/15/2022	State Street Corp	88,797	$0.53M	0.0%	-4.9%	0.230%
8/15/2022	PDT Partners LLC	10,165	$60K	0.0%	N/A	0.026%
8/15/2022	Cubist Systematic Strategies LLC	62,544	$0.37M	0.0%	-70.8%	0.162%
8/15/2022	Millennium Management LLC	828,796	$4.90M	0.0%	+291.0%	2.144%
8/13/2022	Renaissance Technologies LLC	94,300	$0.56M	0.0%	N/A	0.244%
8/12/2022	Northern Trust Corp	74,808	$0.44M	0.0%	-5.4%	0.194%
8/12/2022	FMR LLC	70,002	$0.41M	0.0%	-19.0%	0.181%
8/12/2022	Franklin Resources Inc.	17,621	$0.10M	0.0%	N/A	0.046%
8/11/2022	JPMorgan Chase & Co.	284,558	$1.68M	0.0%	-18.7%	0.736%
8/9/2022	Lazard Asset Management LLC	10,283	$60K	0.0%	-41.8%	0.027%
8/8/2022	Walleye Capital LLC	38,906	$0.23M	0.0%	-74.2%	0.101%
8/5/2022	Landscape Capital Management L.L.C.	16,306	$96K	0.0%	N/A	0.042%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	120,231	$0.71M	0.0%	-10.0%	0.313%
8/4/2022	TD Asset Management Inc.	54,300	$0.32M	0.0%	N/A	0.141%
7/27/2022	Assenagon Asset Management S.A.	19,741	$0.12M	0.0%	N/A	0.051%
7/21/2022	Belvedere Trading LLC	26,432	$0.18M	0.0%	-27.3%	0.069%
7/19/2022	Commonwealth Equity Services LLC	24,334	$0.14M	0.0%	N/A	0.063%
7/19/2022	Harvest Investment Services LLC	42,312	$0.25M	0.2%	N/A	0.110%
6/7/2022	Bank of America Corp DE	87,867	$0.67M	0.0%	+620.2%	0.228%
5/27/2022	Walleye Capital LLC	150,667	$1.15M	0.0%	N/A	0.392%
5/17/2022	Walleye Capital LLC	150,667	$1.15M	0.0%	N/A	0.392%
5/17/2022	Virtu Financial LLC	18,443	$0.14M	0.0%	+79.0%	0.048%
5/16/2022	Goldman Sachs Group Inc.	113,560	$0.87M	0.0%	+241.2%	0.295%
5/16/2022	State Street Corp	93,397	$0.71M	0.0%	+10.1%	0.243%
5/16/2022	UBS Group AG	4,125	$31K	0.0%	-38.0%	0.011%
5/13/2022	Northern Trust Corp	79,119	$0.60M	0.0%	+2.2%	0.206%
5/13/2022	Charles Schwab Investment Management Inc.	15,910	$0.12M	0.0%	N/A	0.041%
5/13/2022	Lazard Asset Management LLC	17,678	$0.13M	0.0%	+144.7%	0.046%
5/13/2022	Vanguard Group Inc.	1,927,787	$14.69M	0.0%	-7.0%	5.012%
5/12/2022	BlackRock Inc.	514,155	$3.92M	0.0%	+10.6%	1.337%
5/12/2022	Acadian Asset Management LLC	247,970	$1.89M	0.0%	-54.8%	0.645%
5/12/2022	Citigroup Inc.	24,461	$0.19M	0.0%	N/A	0.064%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	133,572	$1.02M	0.0%	-9.5%	0.347%
5/11/2022	Raymond James Financial Services Advisors Inc.	35,444	$0.27M	0.0%	-20.0%	0.092%
5/11/2022	JPMorgan Chase & Co.	350,217	$2.67M	0.0%	-32.0%	0.911%
5/6/2022	Koss Olinger Consulting LLC	17,636	$0.13M	0.0%	-10.8%	0.046%
4/20/2022	Belvedere Trading LLC	36,340	$0.35M	0.0%	+4.9%	0.095%
2/10/2022	Acadian Asset Management LLC	548,070	$1.48M	0.0%	-29.0%	1.444%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	147,534	$0.40M	0.0%	+359.2%	0.389%
2/8/2022	Raymond James Financial Services Advisors Inc.	44,303	$0.12M	0.0%	-34.4%	0.117%
2/7/2022	Koss Olinger Consulting LLC	19,777	$54K	0.0%	N/A	0.052%
2/4/2022	IndexIQ Advisors LLC	89,662	$0.24M	0.0%	-6.1%	0.236%
1/31/2022	Focused Wealth Management Inc	10,000	$27K	0.0%	N/A	0.026%
1/25/2022	Belvedere Trading LLC	34,657	$98K	0.0%	-44.7%	0.091%
11/22/2021	EcoR1 Capital LLC	445,992	$1.17M	0.0%	N/A	1.175%
11/16/2021	Squarepoint Ops LLC	33,257	$87K	0.0%	-62.2%	0.088%
11/15/2021	GSA Capital Partners LLP	234,981	$0.62M	0.1%	-4.5%	0.619%
11/12/2021	Renaissance Technologies LLC	315,127	$0.83M	0.0%	-19.3%	0.830%
11/12/2021	Fiduciary Trust Co.	248,529	$0.65M	0.0%	+60.0%	0.655%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	32,130	$85K	0.0%	N/A	0.085%
11/10/2021	IndexIQ Advisors LLC	95,456	$0.25M	0.0%	+11.1%	0.251%
11/9/2021	BlackRock Inc.	930,735	$2.45M	0.0%	-1.3%	2.452%
11/8/2021	Russell Investments Group Ltd.	54,298	$0.14M	0.0%	-18.8%	0.143%
11/2/2021	Raymond James Financial Services Advisors Inc.	67,515	$0.18M	0.0%	-4.8%	0.178%
10/28/2021	WINTON GROUP Ltd	24,287	$64K	0.0%	+33.2%	0.064%
10/19/2021	Belvedere Trading LLC	62,691	$0.29M	0.0%	N/A	0.165%
10/19/2021	Assenagon Asset Management S.A.	52,547	$0.14M	0.0%	-44.2%	0.139%
9/3/2021	Parametric Portfolio Associates LLC	15,000	$62K	0.0%	N/A	0.040%
8/25/2021	Marshall Wace LLP	21,852	$90K	0.0%	-33.2%	0.058%
8/17/2021	Zebra Capital Management LLC	53,360	$0.22M	0.3%	-9.7%	0.141%
8/17/2021	Millennium Management LLC	517,862	$2.14M	0.0%	N/A	1.365%
8/17/2021	Bridgeway Capital Management LLC	156,300	$0.65M	0.0%	-40.9%	0.412%
8/16/2021	Squarepoint Ops LLC	87,960	$0.36M	0.0%	+518.2%	0.232%
8/16/2021	AQR Capital Management LLC	166,330	$0.69M	0.0%	-54.1%	0.438%
8/16/2021	LMR Partners LLP	17,018	$70K	0.0%	N/A	0.045%
8/16/2021	PDT Partners LLC	36,800	$0.15M	0.0%	-58.7%	0.097%
8/16/2021	Occudo Quantitative Strategies LP	21,334	$88K	0.0%	N/A	0.056%
8/16/2021	Morgan Stanley	734,609	$3.04M	0.0%	+58.6%	1.936%
8/16/2021	Charles Schwab Investment Management Inc.	114,256	$0.47M	0.0%	-30.7%	0.301%
8/16/2021	State Street Corp	84,814	$0.35M	0.0%	-82.7%	0.224%
8/16/2021	Tibra Equities Europe Ltd	76,000	$0.31M	0.1%	N/A	0.200%
8/16/2021	Federated Hermes Inc.	678,325	$2.80M	0.0%	+148.1%	1.788%
8/16/2021	Goldman Sachs Group Inc.	174,189	$0.72M	0.0%	+222.9%	0.459%
8/16/2021	Marshall Wace LLP	21,852	$90K	0.0%	-33.2%	0.058%
8/13/2021	Renaissance Technologies LLC	390,390	$1.61M	0.0%	-8.2%	1.029%
8/13/2021	Northern Trust Corp	84,295	$0.35M	0.0%	-73.1%	0.222%

Data available starting January 2016

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $6.22

$6.22

$6.65

50 Day Range

MA: $5.64

$4.79

$6.71

52 Week Range

Now: $6.22

$2.54

$10.60

Volume

7,262 shs

Average Volume

403,434 shs

Market Capitalization

$240.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Who are the company insiders with the largest holdings of Voyager Therapeutics?: Voyager Therapeutics' top insider investors include:
Rock Ventures Iii LP Third (Major Shareholder)
Ecor1 Capital, Llc (Major Shareholder)
Andre Turenne (CEO)
Robert W Hesslein (VP)
Robin Swartz (COO)
Allison Dorval (CFO)
Glenn Pierce (Director)
Julie Burek (VP)
Omar Khwaja (Insider)
Learn More about top insider investors at Voyager Therapeutics.
Who are the major institutional investors of Voyager Therapeutics?: Voyager Therapeutics' top institutional shareholders include:
TRV GP Iii LLC — 14.05%
Armistice Capital LLC — 8.80%
Vanguard Group Inc. — 4.91%
Price T Rowe Associates Inc. MD — 2.19%
Federated Hermes Inc. — 1.57%
BlackRock Inc. — 1.53%
Learn More about top institutional investors of Voyager Therapeutics stock.
Which major investors are selling Voyager Therapeutics stock?: During the previous quarter, VYGR stock was sold by these institutional investors:
TRV GP Iii LLC
Vanguard Group Inc.
Cubist Systematic Strategies LLC
Jane Street Group LLC
Dimensional Fund Advisors LP
Jump Financial LLC
Connor Clark & Lunn Investment Management Ltd.
Federated Hermes Inc.
Within the last year, company insiders that have sold Voyager Therapeutics company stock include:
Rock Ventures Iii LP Third (Major Shareholder)
Ecor1 Capital, Llc (Major Shareholder)
Andre Turenne (CEO)
Robert W Hesslein (VP)
Robin Swartz (COO)
Learn More investors selling Voyager Therapeutics stock.
Which major investors are buying Voyager Therapeutics stock?: In the last quarter, VYGR stock was bought by institutional investors including:
Armistice Capital LLC
Point72 Asset Management L.P.
Marshall Wace LLP
Hillsdale Investment Management Inc.
Bailard Inc.
BlackRock Inc.
Renaissance Technologies LLC
Price T Rowe Associates Inc. MD